Publisher
Springer Science and Business Media LLC
Reference157 articles.
1. Psarras, A., Emery, P. & Vital, E. M. Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy. Rheumatology 56, 1662–1675 (2017).
2. Ronnblom, L. & Alm, G. V. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 22, 427–431 (2001).
3. Walling, H. W. & Sontheimer, R. D. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am. J. Clin. Dermatol. 10, 365–381 (2009).
4. Vital, E. M. et al. B cell biomarkers of rituximab responses in systemic lupus erythematosus. Arthritis Rheum. 63, 3038–3047 (2011).
5. Vital, E. M. et al. Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis Rheumatol. 67, 1586–1591 (2015).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献